Aprio Wealth Management, LLC

Position in ABBV — AbbVie Inc.

CIK 1803519 ATLANTA, GA

Position in ABBV

as of Jun 30, 2026 · filed Jul 24, 2026 Compact

Position Value

$2,624,605

+$383,371 QoQ

Shares Held

10,430

+1.2% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.47%

of 13F equity value

Holder Rank

#1,745

of 4,153 holders

Holding Since

Jun 2022

15 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Aprio Wealth Management, LLC holds $32,790,600 across 13 Drug Manufacturers - General names. ABBV ranks #5 (8.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	7,052	$8,458,381
2	JNJ	Johnson & Johnson	21,754	$5,524,863
3	MRK	Merck & Co., Inc.	35,856	$4,607,496
4	BMY	Bristol Myers Squibb Co	68,912	$3,970,709
5	ABBV	AbbVie Inc. This page	10,430	$2,624,605
6	GILD	Gilead Sciences, Inc.	15,500	$1,958,270
7	NVS	Novartis AG	8,513	$1,334,157
8	AMGN	Amgen Inc	3,328	$1,205,135

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,624,605	10,430	+1.2%	Shares	Sole	2026-07-24
2026-03-31	$2,241,234	10,305	-1.5%	Shares	Sole	2026-05-11
2025-12-31	$2,390,919	10,464	+75.5%	Shares	Sole	2026-01-29
2025-09-30	$1,380,441	5,962	+12.3%	Shares	Sole	2025-11-12
2025-06-30	$985,085	5,307	-11.9%	Shares	Sole	2025-08-14
2025-03-31	$1,262,148	6,024	+9.4%	Shares	Sole	2025-05-15
2024-12-31	$978,593	5,507	+5.8%	Shares	Sole	2025-01-13
2024-09-30	$1,028,080	5,206	+32.1%	Shares	Sole	2024-10-08
2024-06-30	$675,960	3,941	-0.1%	Shares	Sole	2024-07-10
2024-03-31	$718,202	3,944	+40.5%	Shares	Sole	2024-04-10
2023-12-31	$435,155	2,808	-18.8%	Shares	Sole	2024-01-17
2023-09-30	$515,747	3,460	+103.9%	Shares	Sole	2023-10-10
2023-03-31	$270,450	1,697	+10.4%	Shares	Sole	2023-04-14
2022-12-31	$248,394	1,537	-21.3%	Shares	Sole	2023-01-11
2022-06-30	$299,274	1,954	—	Shares	Sole	2022-07-26
No filing history on record for this holder in this stock.